Skip to main content
Truhout big pharma

Before COVID-19, Big Pharma Was Neglecting Vaccine and Antiviral Research

Drug companies have historically pleased investors by promoting vaccine development programs during disease outbreaks, then quietly dropping them later, according to Dana Brown, director of The Next System Project, a research and development lab for political-economic alternatives. Despite an outbreak raging in the Republic of Congo, the British drug maker GlaxoSmithKline recently gave up its effort to develop a vaccine for Ebola and handed off its research to a nonprofit lab. Ebola is deadly but relatively rare globally, and the market was too small to generate significant profits. In 2017, the massive French drug maker Sanofi pulled out of a partnership with the U.S. Army to develop a vaccine for the mosquito-borne Zika virus.

Read the entire article at Truthout.

Publication date: 2020-04-23
Parent publication: Truthout
Publication URL: https://truthout.org/articles/before-covid-19-big-pharma-was-neglecting-vaccine-and-antiviral-research/

More related work

Default Image

Healthcare as a public service: Redesigning U.S. healthcare with health and equity at the center

The Veterans Health Administration—the country’s only fully public, integrated healthcare system—has a lot to tell us about how a national healthcare service for the United States might operate.

read more
Default Image

Preston is putting socialist policies into practice

Labor movements must pursue a social and economic vision that can address the deep structural inequalities these pandemic years have exposed. Preston gives a glimpse of the exciting possibilities that collaboration with unions could achieve.

read more
Default Image

This must be the year of climate action—we've wasted so many

The climate issue has grown too large and devastating to ignore. We need the demand for action raised to the highest decibel our civil society can generate.

read more